These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11847575)

  • 1. Hepatocellular carcinoma: contrast-enhanced MRI.
    Yu JS; Kim MJ
    Abdom Imaging; 2002; 27(2):157-67. PubMed ID: 11847575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 3. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
    Ito K
    Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
    Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
    J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver.
    Br J Radiol; 2016 Oct; 89(1066):20150117e. PubMed ID: 27572243
    [No Abstract]   [Full Text] [Related]  

  • 7. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The recent progress of MRI].
    Nawano S; Nasu K; Murakami K; Kuroki Y; Fujikawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():288-91. PubMed ID: 11761958
    [No Abstract]   [Full Text] [Related]  

  • 12. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation.
    Nishie A; Kakihara D; Asayama Y; Ushijima Y; Takayama Y; Fujita N; Shimamoto D; Shirabe K; Hida T; Honda H
    Clin Radiol; 2015 Mar; 70(3):254-61. PubMed ID: 25522901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging after local tumor therapies: kidney and liver.
    Kielar AZ; Hibbert RM; Maturen KE
    Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378
    [No Abstract]   [Full Text] [Related]  

  • 14. Ferucarbotran-enhanced magnetic resonance imaging versus gadoxetic acid-enhanced magnetic resonance imaging for the preoperative detection of hepatocellular carcinoma: initial experience.
    Lee JY; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ
    J Comput Assist Tomogr; 2010 Jan; 34(1):127-34. PubMed ID: 20118735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
    Kitoh Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MR contrast agent: resovist (SH U 555A)].
    Nakajima H; Ichikawa T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging.
    Okada M; Imai Y; Kim T; Kogita S; Takamura M; Kumano S; Onishi H; Hori M; Fukuda K; Hayashi N; Wakasa K; Sakamoto M; Murakami T
    J Magn Reson Imaging; 2010 Oct; 32(4):903-13. PubMed ID: 20882621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study.
    Sheng RF; Zeng MS; Rao SX; Ji Y; Chen LL
    Clin Imaging; 2014; 38(3):265-72. PubMed ID: 24559750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.